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Introduction 
The Maine Cancer Registry collects information on all cancer cases diagnosed in Maine according to 
State Law Title 22, Chapter 255.  The 2011 annual report is based on 2008 cancer incidence and 2007 
cancer mortality data, and provides information on the most frequently diagnosed cancer types in 
Maine.   
 
The purpose of this report is to summarize data on newly diagnosed cases of cancer (incidence) and 
deaths associated with cancer (mortality) among Maine residents.   Data are also presented at the 
county and public health district levels for all cancer types combined, the top four cancers in Maine 
(namely: female breast, prostate, lung, and colorectal cancers), and tobacco-related cancers 
combined (excluding lung cancer).   
 
The information contained in this report may be used in conjunction with other data sources to 
determine disease burden, and to guide programs and policies targeted at reducing the impact of 
cancer.   
 
Summary of New Features: The following is a summary of new features added to this report in recent 
years: 
 Age-specific incidence data are presented for the top four cancer sites in Maine. 
 Data are presented for malignant and non-malignant incident cases of brain and other nervous 
system tumors.  
 Data are presented for “tobacco-related cancers”.  
 For national comparisons, rates for all races are provided in addition to rates for whites. 
 County-level and public health district-level maps of incidence and mortality rates for all cancer 
types combined are provided. 
 
Technical Notes 
Tobacco-related Cancers:  Tobacco-related cancers excluding lung cancer are included in this report 
due to their increasing clinical and epidemiologic significance.  According to a 2008 MMWR 
surveillance summary (Surveillance for Cancers Associated with Tobacco Use — United States, 1999–
2004), tobacco-related cancers are those that are defined by the U.S. Surgeon General as having 
direct causal relationships to tobacco use.  The list of tobacco-related cancers was expanded in 2004 
to include the following: lung, laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and 
renal pelvis, urinary bladder, and cervical cancers, and acute myeloid leukemia.   
 
Data Sources:  Maine incidence data are obtained from the Maine Cancer Registry. Estimates of 
national incidence data are derived from the Surveillance, Epidemiology and End Results (SEER) 
Program of the National Cancer Institute. The SEER dataset used in this report (SEER 9) represents 
about 9.5% of the U.S. population.  Mortality data for both Maine and the U.S. is provided by the 
National Center for Health Statistics.   
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Data Analysis:  Counts and rates presented in this report were produced using the following 
software: Surveillance Research Program, National Cancer Institute SEER*Stat software 
(seer.cancer.gov/seerstat) 7.0.4. 
 
National Comparisons:  SEER incidence rates and national mortality rates for both whites and all 
races have been provided to allow an option for comparison by the reader.  However due to the 
predominately white population in Maine, all statistical comparisons in this report involving national 
estimates are based on rates for whites.  
 
SEER Rates:  SEER whites and SEER all races refer to estimates of national cancer incidence data.  
 
Rates:  Incidence rates are calculated per 100,000 and are age-adjusted to the year 2000 U.S. 
standard population.   
 
Confidence Intervals and Statistical Significance:  Ninety-five percent confidence intervals are 
provided for all rates. When comparing county-level or public health district-level rates with state 
(Maine) rates, we used the SEER*Stat program to test for statistically significant differences. 
SEER*Stat is unable to test for statistical significant differences between state rates and national 
rates, however, because these rates come from two different datasets.  Hence, we compared 95% 
confidence intervals of Maine and U.S. rates. If the 95% confidence intervals for two rates 
overlapped, the incidence rates were considered similar. If the confidence intervals did not overlap, 
we considered these rates to be significantly different.  Maine rates that are higher than nationally 
comparable rates or county/district rates that are higher than State (Maine) rates are highlighted in 
Turquoise color (xxx).  
 
Maine Public Health Districts:  In 2007, Governor Baldacci announced a new public health 
infrastructure for Maine.  Within this plan, the Maine Center for Disease Control and Prevention 
created eight public health districts with the intent of regionalizing public health services.  Each 
district is made up of one or more counties.  For this reason, cancer rates have been calculated for 
districts in addition to counties.  The table below shows the constituent counties of each district. 
 
Public Health District Constituent Counties 
1. Aroostook District Aroostook County 
2. Central District Kennebec County, Somerset County 
3. Cumberland District Cumberland County 
4. Downeast District Hancock County, Washington County 
5. Midcoast District 
Lincoln County, Knox County, Sagadahoc County, Waldo 
County 
6. Penquis District Penobscot County, Piscataquis County 
7. Western District Androscoggin County, Franklin County, Oxford County 
8. York District York County 
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Rates by County/District:  More so than at the state level, the number of new cancer cases reported 
in a county or district varies from year to year, and much of this variation may be due purely to 
chance.  As a result, cancer rates at the county or district level are more likely to vary on an annual 
basis than at the state level.  Counties/districts with smaller populations tend to have greater 
variation from one time period to the next.  In general, when there are less than 30 cases a year, it 
can be difficult to distinguish between normal variation and meaningful changes in cancer rates.  In 
this report, multiple years of data are combined when producing the county or district rates.  
Although combining years makes the rates more reliable, caution must still be used when 
interpreting county rates. 
 
Maps: This year we have added maps to present the geographical distribution of ‘All Cancer 
Combined’ incidence and mortality rates. These maps were prepared at the county as well as the 
public health district level. For mortality maps, 2004-2008 rates were used instead of 2003-2007 
rates, since 2008 mortality data is the most recent data available for Maine. We used 2003-2007 
rates for the tables because they are more suitable for comparison with U.S. mortality rates, which 
were currently only available through the year 2007. Maps were created using ArcGIS v.10 software; 
the ‘natural breaks’ method was used to categorize the rates.   
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Case Definitions 
Incidence Case Definitions:  Incidence data are based on SEER Site Recode ICD-O-3 Definitions, 
version 1/27/2003: Available at http://seer.cancer.gov/siterecode.  Histologies consistent with 
Kaposi Sarcoma and Mesothelioma are excluded (where applicable).  
 
Mortality Case Definitions: Death data are based on ICD-10 codes for underlying cause of death as 
defined below: 
 
Site ICD-10 Codes 
All Sites C00–C97  
Brain and Other Nervous System C70-C72 
Breast C50 
Cervix Uteri C53 
Colon and Rectum C18-C20, C26.0 
Corpus Uterus C54, C55 
Esophagus C15 
Hodgkin Lymphoma C81 
Kidney and Renal Pelvis C64-C65 
Larynx C32 
Leukemia C90.1, C91-C95 
Liver & Intrahepatic Bile Duct C22.0-C22.4, C22.7, C22.9 
Lung and Bronchus C34 
Melanoma of the Skin C43 
Myeloma C90.0, C90.2 
Non-Hodgkin Lymphoma C82-C85, C96.3 
Oral Cavity and Pharynx C00-C14 
Ovary C56 
Pancreas C25 
Prostate C61 
Stomach C16 
Testis C62 
Thyroid C73 
Urinary Bladder C67 
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Incidence: State and National Comparisons 
 
Age-adjusted Cancer Incidence Rates by Site  
Maine, 2008 
     
 Total 
 AA Rate (95% CI) Count SEER Whites SEER All Races 
All Sites 499.6 (488.6, 510.7) 8172 469.3 (466.5, 472.2) 463.4 (460.9, 465.9) 
Tobacco-related, Excl. Lung 88.4 (83.9, 93.2) 1448 81.8 (80.6, 83.0) 81.2 (80.1, 82.2) 
Lung and Bronchus 75.7 (71.5, 80.0) 1249 59.3 (58.3, 60.4) 58.8 (57.9, 59.7) 
Colon and Rectum 44.4 (41.2, 47.8) 731 43.4 (42.6, 44.3) 44.3 (43.5, 45.1) 
Breast See page 9 and 10 for gender specific rates 
Prostate See page 9 for gender specific rates 
Urinary Bladder 25.8 (23.4, 28.5) 423 22.6 (22.0, 23.2) 20.7 (20.2, 21.2) 
Non-Hodgkin Lymphoma 21.6 (19.3, 24.1) 345 20.9 (20.3, 21.5) 20.2 (19.7, 20.7) 
Melanoma of the Skin 19.7 (17.6, 22.1) 312 27.6 (26.9, 28.3) 22.5 (22.0, 23.1) 
Kidney & Renal Pelvis 15.7 (13.8, 17.8) 254 15.3 (14.8, 15.8) 15.4 (14.9, 15.8) 
Leukemia 14.6 (12.7, 16.6) 232 13.2 (12.7, 13.7) 12.7 (12.2, 13.1) 
Thyroid 13.0 (11.2, 15.1) 187 13.8 (13.3, 14.3) 13.0 (12.6, 13.4) 
Pancreas 12.8 (11.1, 14.6) 213 12.1 (11.6, 12.5) 12.4 (12.0, 12.8) 
Oral Cavity & Pharynx 10.9 (9.4, 12.7) 181 11.1 (10.7, 11.6) 10.8 (10.4, 11.2) 
Brain & Other Nerv. System 7.5 (6.2, 9.1) 114 7.3 (6.9, 7.6) 6.5 (6.2, 6.8) 
Esophagus 6.2 (5.1, 7.5) 107 4.8 (4.5, 5.0) 4.6 (4.3, 4.8) 
Stomach 6.0 (4.8, 7.3) 96 6.0 (5.6, 6.3) 7.1 (6.8, 7.4) 
Myeloma 5.5 (4.4, 6.8) 93 5.3 (5.0, 5.6) 5.8 (5.5, 6.1) 
Liver & Intrahep. Bile Duct 4.6 (3.6, 5.7) 77 6.1 (5.8, 6.4) 7.3 (7.0, 7.7) 
Larynx 4.3 (3.3, 5.4) 72 3.1 (2.9, 3.3) 3.1 (2.9, 3.3) 
Hodgkin Lymphoma 2.9 (2.0, 4.0) 38 3.1 (2.9, 3.3) 2.9 (2.7, 3.1) 
Mesothelioma 1.5 (1.2, 1.9) 25 1.1 (1.0, 1.1) 0.9 (0.9, 1.0) 
Testis See page 9 for gender specific rates 
Corpus Uteri See page 10 for gender specific rates 
Cervix Uteri See page 10 for gender specific rates 
Ovary See page 10 for gender specific rates 
Notes: 
   Maine rate is significantly higher than SEER White rate 
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal   
     pelvis, urinary bladder, and cervical cancers, and acute myeloid leukemia. These cancers are also reported separately in  
     the table. 
 Cancer sites are ordered by descending  incidence rates 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
        Excl. = Excluding; Nerv. = Nervous; Intrahep.= Intrahepatic 
Data Sources: 
 Maine Incidence: Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
 National Incidence: Surveillance, Epidemiology and End Results, SEER 9 Regs Limited-Use, Nov 2010 Sub (1973-2008) 
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Age-adjusted Cancer Incidence Rates by Site 
Maine, 2008 
     
 Male 
 AA Rate (95% CI) Count SEER Whites SEER All Races 
All Sites 568.6 (551.3, 586.4) 4222 531.0 (526.6, 535.5) 530.8 (526.8, 534.9) 
Prostate 147.8 (139.3, 156.7) 1163 146.3 (144.0, 148.6) 153.0 (150.9, 155.2) 
Tobacco-related, Excl. Lung 126.6 (118.4, 135.2) 929 117.7 (115.6, 119.8) 115.5 (113.6, 117.4) 
Lung and Bronchus 89.9 (83.1, 97.1) 664 68.8 (67.1, 70.4) 70.3 (68.8, 71.8) 
Colon and Rectum 49.8 (44.7, 55.3) 363 49.2 (47.9, 50.6) 50.4 (49.2, 51.7) 
Breast 2.9 (1.7, 4.5) 20 1.2 (1.0, 1.5) 1.2 (1.0, 1.4) 
Urinary Bladder 45.5 (40.6, 50.8) 322 39.6 (38.4, 40.9) 36.4 (35.3, 37.5) 
Non-Hodgkin Lymphoma 28.7 (24.8, 33.0) 206 25.5 (24.5, 26.5) 24.7 (23.8, 25.5) 
Melanoma of the Skin 22.9 (19.5, 26.7) 172 34.1 (32.9, 35.2) 28.3 (27.4, 29.3) 
Kidney & Renal Pelvis 20.4 (17.3, 24.1) 152 20.6 (19.7, 21.5) 20.9 (20.1, 21.7) 
Leukemia 17.4 (14.4, 20.8) 124 17.1 (16.3, 17.9) 16.3 (15.6, 17.0) 
Oral Cavity & Pharynx 15.3 (12.7, 18.5) 120 16.5 (15.7, 17.2) 16.0 (15.3, 16.7) 
Pancreas 14.4 (11.7, 17.5) 106 13.9 (13.2, 14.7) 14.2 (13.6, 14.9) 
Esophagus 11.3 (9.0, 14.0) 88 8.4 (7.8, 8.9) 8.0 (7.5, 8.5) 
Stomach 9.0 (6.9, 11.6) 63 8.7 (8.1, 9.3) 10.0 (9.5, 10.6) 
Brain & Other Nerv. System 8.8 (6.7, 11.4) 63 8.5 (8.0, 9.1) 7.7 (7.3, 8.2) 
Liver & Intrahep. Bile Duct 7.3 (5.5, 9.6) 55 9.3 (8.7, 9.9) 11.2 (10.7, 11.8) 
Testis 7.0 (5.0, 9.5) 42 7.1 (6.6, 7.6) 5.9 (5.5, 6.3) 
Larynx 6.6 (4.9, 8.8) 50 5.5 (5.0, 6.0) 5.4 (5.1, 5.9) 
Thyroid 6.4 (4.6, 8.6) 47 6.8 (6.3, 7.3) 6.5 (6.0, 6.9) 
Myeloma 6.1 (4.4, 8.2) 44 6.7 (6.2, 7.2) 7.1 (6.7, 7.6) 
Hodgkin Lymphoma 3.2 (1.9, 4.9) 21 3.5 (3.1, 3.8) 3.3 (3.0, 3.6) 
Mesothelioma 2.7 (2.0, 3.6) 18 1.9 (1.7, 2.0) 1.7 (1.6, 1.8) 
 
Notes: 
      
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal   
     pelvis, urinary bladder, and cervical cancers, and acute myeloid leukemia. These cancers are also reported separately in  
     the table. 
 Cancer sites are ordered by descending  incidence rates 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
        Excl. = Excluding; Nerv. = Nervous; Intrahep.= Intrahepatic 
Data Sources: 
 Maine Incidence: Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
 National Incidence: Surveillance, Epidemiology and End Results, SEER 9 Regs Limited-Use, Nov 2010 Sub (1973-2008) 
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Age-adjusted Cancer Incidence Rates by Site 
Maine, 2008 
     
 Female 
 AA Rate (95% CI) Count SEER Whites SEER All Races 
All Sites 449.7 (435.4, 464.3) 3950 427.1 (423.4, 430.8) 416.3 (413.1, 419.6) 
Breast 124.8 (117.3, 132.6) 1091 129.5 (127.5, 131.5) 127.2 (125.5, 129.0) 
Lung and Bronchus 65.1 (59.9, 70.7) 585 52.8 (51.5, 54.1) 50.6 (49.4, 51.7) 
Tobacco-related, Excl. Lung 58.4 (53.4, 63.8) 519 53.6 (52.3, 54.9) 54.6 (53.5, 55.8) 
Colon and Rectum 39.9 (35.8, 44.3) 368 38.6 (37.5, 39.7) 39.2 (38.3, 40.2) 
Prostate See page 9 for gender specific rates 
Corpus Uteri 31.7 (28.1, 35.8) 282 26.4 (25.5, 27.3) 26.0 (25.2, 26.8) 
Thyroid 19.3 (16.2, 22.9) 140 20.8 (20.0, 21.7) 19.4 (18.7, 20.1) 
Melanoma of the Skin 17.3 (14.4, 20.5) 140 23.1 (22.3, 24.0) 18.5 (17.8, 19.2) 
Non-Hodgkin Lymphoma 15.9 (13.3, 18.9) 139 17.1 (16.4, 17.9) 16.6 (15.9, 17.2) 
Leukemia 12.4 (10.1, 15.1) 108 10.1 (9.6, 10.7) 9.8 (9.3, 10.3) 
Kidney & Renal Pelvis 11.7 (9.5, 14.3) 102 10.8 (10.3, 11.4) 10.8 (10.3, 11.4) 
Pancreas 11.3 (9.2, 13.8) 107 10.5 (10.0, 11.1) 10.9 (10.4, 11.5) 
Ovary 11.2 (9.0, 13.7) 99 13.3 (12.6, 14.0) 12.6 (12.1, 13.2) 
Urinary Bladder 11.1 (9.0, 13.6) 101 9.9 (9.3, 10.4) 9.1 (8.6, 9.6) 
Oral Cavity & Pharynx 6.8 (5.1, 8.8) 61 6.4 (6.0, 6.9) 6.3 (5.9, 6.7) 
Brain & Other Nerv. System 6.4 (4.7, 8.5) 51 6.2 (5.8, 6.7) 5.5 (5.1, 5.9) 
Cervix Uteri 5.8 (4.2, 7.9) 44 6.3 (5.8, 6.8) 6.6 (6.2, 7.0) 
Myeloma 5.0 (3.7, 6.7) 49 4.3 (3.9, 4.7) 4.9 (4.5, 5.2) 
Stomach 3.7 (2.6, 5.3) 33 3.7 (3.4, 4.1) 4.9 (4.6, 5.2) 
Hodgkin Lymphoma 2.6 (1.5, 4.2) 17 2.8 (2.5, 3.1) 2.5 (2.3, 2.8) 
Larynx 2.4 (1.5, 3.8) 22 1.1 (0.9, 1.3) 1.1 (1.0, 1.3) 
Liver & Intrahep. Bile Duct 2.3 (1.4, 3.5) 22 3.4 (3.0, 3.7) 4.0 (3.7, 4.3) 
Esophagus 2.0 (1.2, 3.3) 19 1.7 (1.5, 2.0) 1.7 (1.5, 2.0) 
Mesothelioma 0.7 (0.5, 1.2) 7 0.4 (0.4, 0.5) 0.4 (0.3, 0.5) 
 
 
Notes: 
      
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal   
     pelvis, urinary bladder, and cervical cancers, and acute myeloid leukemia. These cancers are also reported separately in  
     the table. 
 Cancer sites are ordered by descending  incidence rates 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population standard 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
        Excl. = Excluding; Nerv. = Nervous; Intrahep.= Intrahepatic 
Data Sources: 
 Maine Incidence: Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
 National Incidence: Surveillance, Epidemiology and End Results, SEER 9 Regs Limited-Use, Nov 2010 Sub (1973-2008) 
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Incidence: By Age 
 
All Cancers: Incidence by Age 
 Maine, 2006-2008 
       
 Total Male Female 
  Rate (95% CI) Count/Yr  Rate (95% CI) Count/Yr  Rate (95% CI) Count/Yr  
0-14 yrs 17.6 (14.6, 21.1) 39 17.8 (13.6, 22.9) 20 17.4 (13.2, 22.6) 19 
15-19 yrs 23.7 (18.3, 30.1) 22 23.4 (16.1, 32.8) 11 24.0 (16.4, 33.8) 11 
20-24 yrs 40.4 (32.9, 49.2) 33 39.5 (29.4, 52.1) 17 41.4 (30.6, 54.7) 16 
25-29 yrs 62.3 (52.4, 73.5) 47 57.4 (44.3, 73.1) 22 67.2 (53.0, 84.1) 25 
30-34 yrs 103.8 (90.6, 118.2) 75 79.1 (63.1, 97.9) 28 127.4 (107.3, 150.3) 47 
35-39 yrs 153.3 (138.6, 169.1) 132 104.9 (87.9, 124.4) 44 199.8 (176.4, 225.5) 88 
40-44 yrs 229.0 (212.1, 246.8) 228 158.1 (138.3, 179.9) 77 296.5 (269.8, 325.1) 151 
45-49 yrs 388.0 (367.1, 409.8) 429 313.6 (286.9, 342.1) 169 459.0 (427.3, 492.4) 260 
50-54 yrs 623.1 (596.0, 651.1) 663 607.9 (569.8, 647.9) 316 637.6 (599.4, 677.5) 347 
55-59 yrs 917.7 (883.2, 953.3) 886 1012.3 (960.8, 1065.9) 482 825.7 (779.9, 873.6) 404 
60-64 yrs 1421.1 (1372.3, 1471.1) 1069 1631.1 (1556.9, 1708.0) 605 1217.1 (1154.0, 1282.7) 465 
65-69 yrs 2019.2 (1951.5, 2088.6) 1120 2470.4 (2362.1, 2582.4) 652 1609.8 (1526.7, 1696.2) 468 
70-74 yrs 2309.7 (2230.0, 2391.6) 1056 2943.8 (2812.0, 3080.2) 625 1760.2 (1665.6, 1858.9) 431 
75-79 yrs 2713.2 (2619.8, 2809.0) 1064 3449.7 (3290.0, 3615.2) 583 2154.5 (2044.7, 2268.7) 480 
80-84 yrs 2815.4 (2706.2, 2927.9) 835 3556.3 (3361.9, 3759.0) 417 2331.6 (2204.4, 2464.2) 418 
85+ yrs 2532.2 (2423.6, 2644.4) 681 3690.0 (3452.3, 3939.7) 299 2034.1 (1918.1, 2155.2) 383 
 
 
 
Notes: 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population. 
 Abbreviations: Rate = Age-specific rate; CI = Confidence Interval; Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Lung Cancer: Incidence by Age 
 Maine, 2006-2008 
       
 Total Male Female 
 Rate (95% CI) Count/Yr Rate (95% CI) Count/Yr  Rate (95% CI) Count/Yr  
40-44 yrs 13.1 (9.3, 17.9) 13 15.1 (9.5, 22.9) 7 11.1 (6.5, 17.8) 6 
45-49 yrs 39.8 (33.3, 47.2) 44 40.2 (31.0, 51.2) 22 39.5 (30.6, 50.1) 22 
50-54 yrs 72.4 (63.3, 82.3) 77 73.8 (60.9, 88.6) 38 71.0 (58.6, 85.1) 39 
55-59 yrs 113.9 (101.9, 126.9) 110 136.5 (118.0, 157.1) 65 91.9 (77.1, 108.8) 45 
60-64 yrs 206.4 (188.1, 226.0) 155 231.1 (203.7, 261.1) 86 182.5 (158.6, 209.0) 70 
65-69 yrs 331.0 (304.0, 359.8) 184 378.9 (337.2, 424.3) 100 287.6 (253.1, 325.5) 84 
70-74 yrs 448.5 (413.8, 485.4) 205 527.8 (472.9, 587.4) 112 379.8 (336.6, 427.1) 93 
75-79 yrs 571.4 (529.0, 616.3) 224 709.7 (638.2, 786.9) 120 466.5 (416.2, 521.2) 104 
80-84 yrs 524.9 (478.3, 574.7) 156 682.8 (599.1, 774.9) 80 421.7 (368.6, 480.3) 76 
85+ yrs 334.5 (295.8, 376.9) 90 572.4 (481.2, 675.9) 46 232.1 (194.1, 275.4) 44 
 
 
Tobacco-related Cancers, Excl. Lung: Incidence by Age 
 Maine, 2006-2008 
       
 Total Male Female 
  Rate (95% CI) Count/Yr  Rate (95% CI) Count/Yr  Rate (95% CI) Count/Yr  
25-34 yrs 9.4 (6.7, 12.7) 14 7.5 (4.3, 12.2) 5 11.2 (7.2, 16.6) 8 
35-39 yrs 22.4 (17.0, 29.0) 19 22.9 (15.3, 32.9) 10 22.0 (14.8, 31.6) 10 
40-44 yrs 41.2 (34.3, 49.2) 41 46.1 (35.7, 58.5) 22 36.6 (27.7, 47.6) 19 
45-49 yrs 62.5 (54.2, 71.6) 69 80.4 (67.2, 95.5) 43 45.4 (35.8, 56.7) 26 
50-54 yrs 99.0 (88.4, 110.5) 105 139.9 (122.0, 159.8) 73 60.0 (48.7, 73.1) 33 
55-59 yrs 159.5 (145.2, 174.7) 154 233.1 (208.8, 259.6) 111 87.8 (73.3, 104.3) 43 
60-64 yrs 243.2 (223.3, 264.4) 183 321.0 (288.6, 356.1) 119 167.6 (144.8, 193.1) 64 
65-69 yrs 361.1 (332.8, 391.1) 200 520.4 (471.3, 573.1) 137 216.5 (186.8, 249.7) 63 
70-74 yrs 431.8 (397.7, 468.0) 197 618.9 (559.3, 683.2) 131 269.5 (233.3, 309.8) 66 
75-79 yrs 508.5 (468.5, 550.9) 199 792.4 (716.9, 873.8) 134 293.0 (253.5, 337.1) 65 
80-84 yrs 532.7 (485.8, 582.9) 158 825.1 (732.8, 925.7) 97 341.8 (294.2, 395.0) 61 
85+ yrs 522.8 (474.1, 575.1) 141 947.2 (828.7, 1077.9) 77 340.2 (293.8, 391.9) 64 
 
 
Notes: 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population. 
 Abbreviations: Rate = Age-specific rate; CI = Confidence Interval; Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Prostate Cancer: Incidence by Age 
Maine, 2006-2008 
   
 Male 
 Rate (95% CI) Count/Yr  
40-49 yrs 24.7 (19.6, 30.6) 28 
50-54 yrs 179.7 (159.3, 202.1) 93 
55-59 yrs 342.3 (312.7, 374.1) 163 
60-64 yrs 604.3 (559.4, 651.7) 224 
65-69 yrs 894.2 (829.5, 962.6) 236 
70-74 yrs 988.1 (912.4, 1068.4) 210 
75-79 yrs 822.0 (745.0, 904.8) 139 
80-84 yrs 728.3 (641.8, 823.2) 85 
85+ yrs 691.9 (591.2, 804.8) 56 
 
 
Female Breast Cancer: Incidence by Age 
Maine, 2006-2008 
   
 Female 
 Rate (95% CI) Count/Yr  
25-29 yrs 8.0 (3.6, 15.1) 3 
30-34 yrs 33.4 (23.5, 46.1) 12 
35-39 yrs 54.7 (42.8, 68.9) 24 
40-44 yrs 111.9 (95.8, 130.0) 57 
45-49 yrs 196.2 (175.7, 218.4) 111 
50-54 yrs 220.3 (198.1, 244.2) 120 
55-59 yrs 279.1 (252.7, 307.5) 137 
60-64 yrs 379.8 (344.9, 417.2) 145 
65-69 yrs 464.0 (419.9, 511.5) 135 
70-74 yrs 417.9 (372.5, 467.4) 102 
75-79 yrs 447.0 (397.8, 500.7) 100 
80-84 yrs 453.3 (398.2, 513.9) 81 
85+ yrs 388.0 (338.3, 443.0) 73 
 
Notes: 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population. 
 Abbreviations: Rate = Age-specific rate; CI = Confidence Interval; Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Colorectal Cancer: Incidence by Age 
 Maine, 2006-2008 
       
 Total Male Female 
 Rate (95% CI) Count/Yr  Rate (95% CI) Count/Yr  Rate (95% CI) Count/Yr  
35-44 yrs 13.5 (10.7, 16.9) 25 12.4 (8.6, 17.4) 11 14.6 (10.5, 19.8) 14 
45-49 yrs 25.3 (20.2, 31.4) 28 29.1 (21.4, 38.7) 16 21.8 (15.3, 30.0) 12 
50-54 yrs 51.1 (43.5, 59.5) 54 55.2 (44.2, 68.2) 29 47.1 (37.2, 58.9) 26 
55-59 yrs 72.5 (63.0, 83.0) 70 79.8 (65.8, 95.9) 38 65.4 (52.9, 79.8) 32 
60-64 yrs 108.5 (95.4, 123.0) 82 133.1 (112.5, 156.3) 49 84.7 (68.7, 103.3) 32 
65-69 yrs 171.8 (152.5, 192.9) 95 203.3 (173.1, 237.3) 54 143.2 (119.2, 170.6) 42 
70-74 yrs 196.2 (173.4, 221.1) 90 213.6 (179.2, 252.7) 45 181.1 (151.6, 214.6) 44 
75-79 yrs 302.7 (272.1, 335.8) 119 352.9 (303.1, 408.5) 60 264.6 (227.1, 306.6) 59 
80-84 yrs 351.8 (313.9, 393.0) 104 367.0 (306.4, 436.1) 43 341.8 (294.2, 395.0) 61 
85+ yrs 417.5 (374.1, 464.5) 112 473.6 (391.0, 568.5) 38 393.4 (343.3, 448.6) 74 
 
 
Notes: 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population. 
 Abbreviations: Rate = Age-specific rate; CI = Confidence Interval; Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Incidence: County and State Comparisons 
 
All Cancers: Incidence by County of Residence 
 Maine, 2006-2008 
       
 Total Male Female 
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  
Androscoggin 526.0 (502.6, 550.2) 644 609.9 (572.2, 649.4) 333 467.9 (437.7, 499.7) 311 
Aroostook 494.3 (468.7, 521.0) 486 566.4 (526.0, 609.2) 255 441.5 (408.1, 477.1) 231 
Cumberland 524.5 (509.8, 539.5) 1651 606.0 (582.2, 630.5) 840 470.1 (451.2, 489.6) 811 
Franklin 513.7 (470.6, 559.8) 181 622.5 (551.5, 700.4) 99 431.2 (377.8, 490.5) 82 
Hancock 541.4 (509.8, 574.6) 383 608.5 (559.3, 661.2) 199 489.9 (448.7, 534.3) 184 
Kennebec 503.7 (482.7, 525.3) 742 562.6 (529.6, 597.2) 374 462.3 (435.0, 491.0) 368 
Knox 514.4 (479.9, 550.9) 291 603.0 (548.1, 662.2) 153 459.1 (413.7, 508.7) 138 
Lincoln 479.8 (444.4, 517.6) 245 516.5 (463.6, 574.4) 123 454.6 (406.7, 507.4) 122 
Oxford 582.1 (549.8, 616.0) 417 677.3 (625.8, 732.0) 224 512.7 (470.8, 557.7) 193 
Penobscot 570.8 (550.1, 592.2) 964 676.5 (642.3, 712.1) 511 493.9 (467.7, 521.3) 453 
Piscataquis 526.1 (472.9, 584.3) 128 601.1 (518.0, 695.1) 67 467.4 (398.7, 546.2) 61 
Sagadahoc 485.4 (447.6, 525.6) 211 560.1 (499.7, 626.0) 111 432.6 (384.1, 485.8) 100 
Somerset 487.4 (456.3, 520.2) 312 553.5 (504.2, 606.5) 162 438.7 (398.5, 482.2) 150 
Waldo 538.0 (499.6, 578.8) 254 593.2 (532.8, 658.8) 127 502.2 (451.9, 557.0) 127 
Washington 553.0 (513.3, 595.3) 250 679.9 (615.1, 750.1) 140 455.2 (405.6, 509.7) 110 
York 505.0 (488.5, 521.9) 1216 591.2 (564.6, 618.8) 644 442.2 (421.2, 464.1) 572 
Maine 522.7 (516.2, 529.3) 8379 603.9 (593.5, 614.6) 4365 464.7 (456.3, 473.3) 4014 
 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Lung Cancer: Incidence by County of Residence 
 Maine, 2006-2008 
       
 Total Male Female 
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  
Androscoggin 88.2 (78.8, 98.4) 108 106.3 (90.9, 123.4) 58 74.1 (62.6, 87.3) 50 
Aroostook 91.0 (80.6, 102.6) 93 126.8 (108.4, 147.6) 58 63.2 (51.5, 77.2) 35 
Cumberland 69.1 (63.9, 74.8) 216 86.5 (77.5, 96.3) 115 57.9 (51.5, 65.0) 101 
Franklin 73.4 (57.6, 92.4) 25 100.2 (72.6, 135.1) 15 53.1 (35.6, 76.8) 10 
Hancock 85.1 (72.9, 98.9) 59 99.2 (79.8, 122.2) 31 74.3 (59.1, 92.7) 28 
Kennebec 75.4 (67.5, 84.0) 112 90.3 (77.4, 104.8) 60 64.4 (54.6, 75.6) 52 
Knox 70.5 (58.4, 84.6) 42 90.8 (70.3, 115.8) 23 56.1 (42.0, 74.2) 19 
Lincoln 62.4 (50.7, 76.4) 34 54.1 (38.5, 75.0) 13 70.1 (53.6, 91.4) 21 
Oxford 87.1 (75.1, 100.6) 64 110.6 (90.3, 134.4) 36 70.9 (56.4, 88.3) 28 
Penobscot 98.0 (89.6, 107.1) 167 116.6 (102.8, 131.9) 88 84.1 (73.7, 95.6) 79 
Piscataquis 82.3 (62.8, 107.0) 21 117.6 (83.3, 163.1) 14 52.4 (32.6, 83.0) 7 
Sagadahoc 66.0 (52.6, 81.9) 28 71.8 (51.5, 97.6) 14 61.3 (44.1, 83.4) 14 
Somerset 82.3 (69.8, 96.5) 52 94.7 (74.9, 118.4) 27 73.5 (57.7, 92.6) 25 
Waldo 82.5 (67.9, 99.4) 39 86.4 (64.7, 113.3) 19 78.4 (59.5, 101.9) 20 
Washington 96.9 (81.0, 115.2) 45 125.1 (98.6, 157.2) 26 74.8 (56.2, 98.4) 19 
York 66.8 (60.9, 73.1) 161 75.2 (65.8, 85.5) 81 61.3 (53.7, 69.8) 80 
Maine 78.4 (75.9, 81.0) 1267 95.0 (90.8, 99.3) 680 66.4 (63.3, 69.6) 587 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Tobacco-related Cancers, Excl. Lung: Incidence by County of Residence 
 Maine, 2006-2008 
       
 Total Male Female 
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  
Androscoggin 106.8 (96.5, 118.0) 132 149.0 (130.7, 169.1) 82 74.4 (62.7, 87.7) 50 
Aroostook 88.5 (77.9, 100.2) 88 128.3 (109.6, 149.6) 58 56.3 (44.9, 70.1) 30 
Cumberland 94.5 (88.3, 101.0) 298 137.8 (126.5, 149.9) 189 62.9 (56.2, 70.3) 109 
Franklin 94.9 (76.8, 116.2) 33 126.5 (95.1, 165.2) 19 71.7 (51.1, 98.6) 14 
Hancock 86.2 (74.0, 100.0) 61 123.8 (102.2, 149.1) 40 55.1 (42.2, 71.2) 21 
Kennebec 89.2 (80.5, 98.6) 130 124.3 (108.9, 141.3) 81 62.0 (52.2, 73.2) 49 
Knox 80.5 (67.4, 95.8) 45 117.1 (93.7, 145.1) 29 52.9 (38.4, 71.7) 16 
Lincoln 90.3 (75.3, 107.8) 46 142.4 (114.9, 175.3) 33 47.6 (33.1, 67.2) 13 
Oxford 99.4 (86.6, 113.8) 73 162.0 (137.2, 190.1) 53 51.1 (38.8, 66.4) 20 
Penobscot 94.4 (86.0, 103.3) 159 138.4 (123.0, 155.1) 103 60.1 (51.3, 70.0) 56 
Piscataquis 95.9 (74.7, 122.3) 24 151.4 (112.0, 201.8) 17 48.9 (29.7, 79.0) 7 
Sagadahoc 76.2 (61.7, 93.2) 33 107.7 (81.9, 139.3) 21 52.1 (36.5, 72.7) 12 
Somerset 88.3 (75.4, 102.9) 57 112.6 (91.4, 137.5) 34 67.0 (51.9, 85.5) 23 
Waldo 87.8 (72.6, 105.5) 41 112.9 (87.8, 143.3) 25 66.7 (48.8, 89.5) 16 
Washington 86.6 (71.5, 104.3) 40 127.5 (100.7, 160.0) 27 54.0 (37.9, 75.3) 13 
York 95.1 (88.1, 102.6) 229 140.1 (127.3, 153.9) 152 58.9 (51.4, 67.2) 77 
Maine 92.6 (89.9, 95.4) 1490 134.0 (129.0, 139.0) 963 60.3 (57.3, 63.4) 527 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Prostate Cancer: Incidence  
by County of Residence  
Maine, 2006-2008 
   
 Male 
 AA Rate (95% CI) Count/Yr  
Androscoggin 160.8 (142.0, 181.5) 90 
Aroostook 107.4 (90.9, 126.4) 51 
Cumberland 168.6 (156.4, 181.5) 245 
Franklin 184.2 (147.1, 228.2) 30 
Hancock 174.2 (149.2, 202.6) 60 
Kennebec 162.8 (145.7, 181.5) 113 
Knox 168.4 (140.8, 200.4) 45 
Lincoln 144.7 (118.8, 175.5) 37 
Oxford 168.1 (144.0, 195.6) 59 
Penobscot 163.9 (147.7, 181.5) 129 
Piscataquis 139.6 (102.2, 188.0) 16 
Sagadahoc 162.4 (131.7, 198.3) 34 
Somerset 164.1 (138.4, 193.4) 50 
Waldo 171.5 (140.0, 208.2) 38 
Washington 180.3 (148.7, 217.4) 39 
York 173.3 (159.4, 188.2) 197 
Maine 163.1 (157.8, 168.6) 1234 
 
Notes: 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Female Breast Cancer: Incidence 
 by County of Residence 
Maine, 2006-2008 
   
 Female 
 AA Rate (95% CI) Count/Yr  
Androscoggin 112.4 (97.8, 128.7) 73 
Aroostook 107.9 (91.7, 126.6) 56 
Cumberland 135.6 (125.5, 146.2) 232 
Franklin 117.1 (90.1, 150.1) 22 
Hancock 136.7 (115.8, 160.8) 53 
Kennebec 135.4 (120.8, 151.3) 108 
Knox 138.2 (113.8, 166.9) 40 
Lincoln 118.5 (95.4, 146.5) 32 
Oxford 144.9 (122.8, 170.1) 54 
Penobscot 127.9 (114.7, 142.3) 116 
Piscataquis 124.3 (92.0, 167.0) 17 
Sagadahoc 136.8 (109.6, 168.9) 30 
Somerset 112.1 (92.4, 135.1) 39 
Waldo 128.3 (103.9, 157.2) 33 
Washington 115.3 (90.7, 145.3) 27 
York 129.7 (118.5, 141.8) 169 
Maine 128.2 (123.8, 132.7) 1101 
 
Notes: 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Colorectal Cancer: Incidence by County of Residence 
Maine, 2006-2008 
       
 Total Male Female 
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  AA Rate (95% CI)] Count/Yr  
Androscoggin 44.5 (37.9, 51.9) 55 49.7 (39.3, 62.1) 26 40.7 (32.3, 50.6) 29 
Aroostook 60.2 (51.6, 69.9) 60 69.8 (55.9, 86.3) 30 52.6 (42.1, 65.4) 30 
Cumberland 44.2 (40.1, 48.7) 142 45.8 (39.4, 53.0) 62 42.9 (37.5, 48.9) 80 
Franklin 56.9 (43.2, 73.8) 20 64.7 (43.1, 93.4) 10 50.9 (33.8, 74.3) 10 
Hancock 46.4 (37.8, 56.7) 35 50.9 (37.9, 67.5) 18 42.3 (31.2, 56.6) 17 
Kennebec 45.2 (39.1, 52.0) 67 49.6 (40.2, 60.7) 33 41.3 (33.6, 50.5) 34 
Knox 41.1 (32.2, 52.2) 24 50.7 (35.5, 70.6) 12 33.5 (23.3, 47.6) 12 
Lincoln 40.6 (31.0, 52.6) 21 43.1 (28.8, 62.9) 10 37.2 (25.4, 54.0) 11 
Oxford 49.1 (40.1, 59.7) 36 51.2 (37.8, 68.1) 17 47.6 (35.8, 62.5) 19 
Penobscot 60.5 (53.8, 67.7) 102 72.3 (61.3, 84.7) 54 51.3 (43.2, 60.6) 48 
Piscataquis 51.9 (36.2, 73.1) 13 38.7 (20.9, 68.1) 5 60.7 (37.6, 95.2) 8 
Sagadahoc 41.8 (31.4, 54.7) 19 57.7 (39.1, 82.1) 11 29.7 (18.7, 45.6) 8 
Somerset 45.3 (36.2, 56.2) 29 48.1 (34.2, 66.0) 14 44.0 (32.1, 59.4) 15 
Waldo 47.9 (37.0, 61.1) 23 55.9 (38.7, 78.4) 12 42.0 (28.6, 60.1) 11 
Washington 61.4 (48.9, 76.5) 29 72.7 (52.6, 98.6) 15 52.1 (36.9, 72.3) 14 
York 45.8 (41.0, 51.1) 111 52.9 (45.1, 61.8) 56 40.3 (34.3, 47.1) 55 
Maine 48.5 (46.5, 50.5) 785 54.2 (51.1, 57.5) 385 43.9 (41.4, 46.5) 400 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Brain and Other Nervous System Tumors: Incidence by County of Residence 
 Maine, 2004-2008 
       
 All Behaviors Malignant Non-malignant  
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI] Count/Yr  AA Rate (95% CI) Count/Yr  
Androscoggin 15.6 (12.4, 19.3) 17 6.7 (4.7, 9.3) 7 8.9 (6.6, 11.7) 10 
Aroostook 16.2 (12.6, 20.6) 15 9.1 (6.5, 12.6) 8 7.1 (4.8, 10.2) 6 
Cumberland 14.3 (12.5, 16.4) 44 8.2 (6.8, 9.8) 25 6.2 (5.0, 7.6) 19 
Franklin 15.0 (9.3, 22.8) 5 8.6 (4.6, 14.8) 3 6.4 (2.8, 12.2) 2 
Hancock 13.2 (9.6, 17.9) 9 5.9 (3.6, 9.4) 4 7.3 (4.7, 11.0) 5 
Kennebec 13.4 (10.7, 16.6) 18 7.6 (5.6, 10.1) 10 5.8 (4.1, 8.1) 8 
Knox 14.7 (10.3, 20.4) 8 7.9 (4.9, 12.3) 4 6.8 (3.9, 11.1) 3 
Lincoln 9.8 (6.1, 15.3) 5 7.1 (3.9, 12.1) 3 2.7 (1.1, 6.1) 1 
Oxford 13.5 (9.7, 18.4) 9 5.3 (3.1, 8.6) 4 8.2 (5.3, 12.2) 5 
Penobscot 16.5 (13.8, 19.7) 26 8.8 (6.8, 11.1) 14 7.8 (5.9, 10.0) 12 
Piscataquis 21.0 (12.6, 33.0) 4 9.0 (3.9, 18.0) 2 12.0 (6.0, 21.8) 2 
Sagadahoc 15.3 (10.2, 22.0) 6 7.6 (4.2, 12.7) 3 7.7 (4.2, 12.9) 3 
Somerset 12.7 (8.8, 17.8) 7 9.0 (5.7, 13.4) 5 3.8 (1.9, 6.8) 2 
Waldo 20.4 (14.8, 27.6) 9 9.7 (6.0, 15.0) 4 10.7 (6.8, 16.2) 5 
Washington 12.4 (8.0, 18.5) 5 6.9 (3.8, 11.8) 3 5.4 (2.7, 10.1) 2 
York 14.0 (11.9, 16.4) 32 7.3 (5.8, 9.1) 17 6.8 (5.3, 8.5) 15 
Maine 14.7 (13.8, 15.6) 219 7.8 (7.2, 8.5) 116 6.9 (6.3, 7.5) 103 
 
 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Incidence: District and State Comparisons 
 
All Cancers: Incidence by Public Health District of Residence 
Maine, 2006-2008 
       
 Total Male Female 
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI] Count/Yr  AA Rate (95% CI) Count/Yr  
Aroostook 494.3 (468.7, 521.0) 486 566.4 (526.0, 609.2) 255 441.5 (408.1, 477.1) 231 
Central 498.9 (481.5, 516.9) 1055 560.3 (532.8, 589.0) 537 454.9 (432.2, 478.6) 518 
Cumberland 524.5 (509.8, 539.5) 1651 606.0 (582.2, 630.5) 840 470.1 (451.2, 489.6) 811 
Downeast 545.5 (520.7, 571.3) 633 636.4 (596.9, 678.0) 339 475.0 (443.2, 508.7) 294 
Midcoast 504.7 (486.4, 523.6) 1001 567.5 (538.8, 597.3) 514 462.3 (438.2, 487.6) 487 
Penquis 564.7 (545.3, 584.6) 1092 665.3 (633.6, 698.1) 579 490.8 (466.2, 516.4) 513 
Western 540.8 (523.3, 558.6) 1242 632.4 (604.3, 661.5) 656 475.3 (452.9, 498.5) 586 
York 505.0 (488.5, 521.9) 1216 591.2 (564.6, 618.8) 644 442.2 (421.2, 464.1) 572 
Maine 522.7 (516.2, 529.3) 8379 603.9 (593.5, 614.6) 4365 464.7 (456.3, 473.3) 4014 
 
Notes: 
   District rate is significantly higher than Maine rate 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
 Count/Yr = Average Annual Count 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Lung Cancer: Incidence by Public Health District of Residence 
Maine, 2006-2008 
       
 Total Male Female 
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  
Aroostook 91.0 (80.6, 102.6) 93 126.8 (108.4, 147.6) 58 63.2 (51.5, 77.2) 35 
Central 77.5 (70.7, 84.7) 164 91.8 (80.8, 103.9) 87 67.0 (58.6, 76.4) 77 
Cumberland 69.1 (63.9, 74.8) 216 86.5 (77.5, 96.3) 115 57.9 (51.5, 65.0) 101 
Downeast 89.5 (79.8, 100.3) 105 109.2 (93.2, 127.2) 58 74.2 (62.3, 88.0) 47 
Midcoast 70.5 (63.9, 77.6) 143 76.5 (66.2, 87.9) 69 66.1 (57.5, 75.7) 74 
Penquis 95.9 (88.1, 104.2) 188 116.2 (103.3, 130.3) 102 80.3 (70.7, 90.8) 86 
Western 85.0 (78.2, 92.2) 197 105.9 (94.6, 118.2) 110 69.5 (61.3, 78.6) 88 
York 66.8 (60.9, 73.1) 161 75.2 (65.8, 85.5) 81 61.3 (53.7, 69.8) 80 
Maine 78.4 (75.9, 81.0) 1267 95.0 (90.8, 99.3) 680 66.4 (63.3, 69.6) 587 
 
Tobacco-related Cancers, Excl. Lung: Incidence 
 by Public Health District of Residence 
Maine, 2006-2008 
       
 Total Male Female 
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  
Aroostook 88.5 (77.9, 100.2) 88 128.3 (109.6, 149.6) 58 56.3 (44.9, 70.1) 30 
Central 88.9 (81.7, 96.7) 187 121.0 (108.3, 134.7) 115 63.4 (55.1, 72.8) 72 
Cumberland 94.5 (88.3, 101.0) 298 137.8 (126.5, 149.9) 189 62.9 (56.2, 70.3) 109 
Downeast 86.1 (76.5, 96.6) 101 125.4 (108.3, 144.7) 67 54.0 (43.8, 66.1) 34 
Midcoast 83.7 (76.3, 91.6) 165 120.5 (107.4, 134.7) 107 54.5 (46.4, 63.7) 58 
Penquis 94.7 (86.8, 103.0) 184 140.1 (125.7, 155.8) 121 58.9 (50.7, 68.1) 63 
Western 102.8 (95.3, 110.7) 238 149.3 (135.7, 163.8) 154 67.3 (59.1, 76.4) 84 
York 95.1 (88.1, 102.6) 229 140.1 (127.3, 153.9) 152 58.9 (51.4, 67.2) 77 
Maine 92.6 (89.9, 95.4) 1490 134.0 (129.0, 139.0) 963 60.3 (57.3, 63.4) 527 
 
Notes: 
   District rate is significantly higher than Maine rate. 
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal    
pelvis, urinary bladder, and cervical cancers, and acute myeloid leukemia 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003). 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
 Excl. = Excluding; Count/Yr = Average Annual Count. 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Prostate Cancer: Incidence  
by Public Health District of Residence  
Maine, 2006-2008 
   
 Male 
 AA Rate (95% CI) Count/Yr  
Aroostook 107.4 (90.9, 126.4) 51 
Central 163.3 (149.0, 178.8) 164 
Cumberland 168.6 (156.4, 181.5) 245 
Downeast 176.7 (156.9, 198.7) 99 
Midcoast 160.0 (145.5, 175.7) 154 
Penquis 160.3 (145.3, 176.4) 145 
Western 166.7 (152.7, 181.7) 179 
York 173.3 (159.4, 188.2) 197 
Maine 163.1 (157.8, 168.6) 1234 
 
 
 
 
Notes: 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
 Count/Yr = Average Annual Count. 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
Female Breast Cancer: Incidence  
by Public Health District of Residence  
Maine, 2006-2008 
   
 Female 
 AA Rate (95% CI) Count/Yr  
Aroostook 107.9 (91.7, 126.6) 56 
Central 128.3 (116.4, 141.1) 146 
Cumberland 135.6 (125.5, 146.2) 232 
Downeast 128.1 (111.9, 146.2) 79 
Midcoast 131.3 (118.5, 145.2) 136 
Penquis 128.0 (115.6, 141.5) 133 
Western 122.6 (111.3, 134.8) 149 
York 129.7 (118.5, 141.8) 169 
Maine 128.2 (123.8, 132.7) 1101 
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Colorectal Cancer: Incidence by Public Health District of Residence  
Maine, 2006-2008 
       
 Total Male Female 
 AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  
Aroostook 60.2 (51.6, 69.9) 60 69.8 (55.9, 86.3) 30 52.6 (42.1, 65.4) 30 
Central 45.4 (40.3, 51.0) 96 49.2 (41.2, 58.3) 46 42.3 (35.7, 49.9) 50 
Cumberland 44.2 (40.1, 48.7) 142 45.8 (39.4, 53.0) 62 42.9 (37.5, 48.9) 80 
Downeast 52.3 (45.0, 60.5) 63 59.4 (48.0, 72.9) 33 46.0 (36.9, 57.1) 30 
Midcoast 43.2 (38.1, 49.0) 88 51.5 (43.0, 61.2) 46 36.4 (30.2, 43.6) 42 
Penquis 59.2 (53.1, 65.9) 114 67.7 (57.8, 78.8) 59 52.2 (44.5, 61.0) 56 
Western 47.7 (42.6, 53.2) 110 52.5 (44.5, 61.4) 53 44.2 (37.7, 51.5) 57 
York 45.8 (41.0, 51.1) 111 52.9 (45.1, 61.8) 56 40.3 (34.3, 47.1) 55 
Maine 48.5 (46.5, 50.5) 785 54.2 (51.1, 57.5) 385 43.9 (41.4, 46.5) 400 
 
 
Brain and Other Nervous System Tumors: Incidence  
by Public Health District of Residence  
Maine, 2004-2008 
       
 All Behaviors Malignant Non-malignant 
  AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr  
Aroostook 16.2 (12.6, 20.6) 14 9.1 (6.5, 12.6) 8 7.1 (4.8, 10.2) 6 
Central 13.2 (11.0, 15.8) 25 8.0 (6.3, 10.1) 15 5.2 (3.8, 6.9) 10 
Cumberland 14.3 (12.5, 16.4) 44 8.2 (6.8, 9.8) 25 6.2 (5.0, 7.6) 19 
Downeast 12.8 (10.0, 16.3) 14 6.3 (4.3, 8.9) 7 6.5 (4.6, 9.1) 7 
Midcoast 15.2 (12.7, 18.0) 28 8.2 (6.4, 10.3) 15 7.0 (5.3, 9.1) 13 
Penquis 17.0 (14.3, 20.0) 30 8.8 (6.9, 11.0) 15 8.2 (6.4, 10.4) 15 
Western 14.8 (12.5, 17.4) 31 6.7 (5.1, 8.5) 14 8.2 (6.5, 10.1) 17 
York 14.0 (11.9, 16.4) 32 7.3 (5.8, 9.1) 17 6.8 (5.3, 8.5) 15 
Maine 14.7 (13.8, 15.6) 219 7.8 (7.2, 8.5) 116 6.9 (6.3, 7.5) 103 
 
 
Notes: 
   District rate is significantly higher than Maine rate 
 Incidence case definitions are based on SEER Site Recode ICD-O-3 (1/27/2003) 
 Incidence case definitions exclude histologies consistent with Kaposi Sarcoma and Mesothelioma, where applicable 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: ONS= Other Nervous System; AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, 
Epidemiology, and End Results; Count/Yr = Average Annual Count All behaviors = Malignant and Non-Malignant. 
 
Data Source: 
 Maine Cancer Registry, 1995-2008 NPCR-CSS Call for Data 
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Mortality: State and National Comparisons 
 
Age-adjusted Cancer Mortality Rates by Site 
Maine, 2007 
     
 Total 
 AA Rate (95% CI) Count US Whites US All Races 
All Malignant Cancers 191.9 (185.2, 198.8) 3112 177.1 (176.6, 177.6) 178.1 (177.7, 178.6) 
Lung and Bronchus 56.3 (52.7, 60.2) 913 51.2 (51.0, 51.5) 50.7 (50.4, 50.9) 
Tobacco-related, Excl. Lung 40.1 (37.0, 43.3) 653 34.2 (34.0, 34.4) 34.7 (34.5, 34.9) 
Colon and Rectum 19.0 (16.9, 21.2) 313 16.2 (16.1, 16.4) 16.7 (16.6, 16.9) 
Breast See page 29 and 30 for gender specific rates 
Prostate See page 29 for gender specific rate 
Pancreas 10.4 (8.9, 12.1) 171 10.6 (10.5, 10.7) 10.8 (10.7, 10.9) 
Urinary Bladder 6.7 (5.5, 8.1) 109 4.5 (4.5, 4.6) 4.4 (4.3, 4.4) 
Leukemia 6.7 (5.4, 8.1) 104 6.2 (6.1, 6.3) 6.0 (5.9, 6.1) 
Non-Hodgkin Lymphoma 6.6 (5.4, 8.1) 105 6.8 (6.7, 6.9) 6.5 (6.4, 6.6) 
Esophagus 5.9 (4.7, 7.2) 96 4.3 (4.3, 4.4) 4.3 (4.2, 4.3) 
Kidney & Renal Pelvis 4.8 (3.8, 6.0) 79 4.1 (4.0, 4.1) 4.0 (3.9, 4.1) 
Liver & Intrahep. Bile Duct 4.7 (3.7, 5.9) 78 5.0 (4.9, 5.0) 5.4 (5.3, 5.4) 
Brain & Other Nerv. System 4.4 (3.4, 5.7) 69 4.6 (4.5, 4.7) 4.2 (4.1, 4.3) 
Stomach 3.6 (2.7, 4.7) 59 3.1 (3.1, 3.2) 3.6 (3.5, 3.7) 
Myeloma 2.9 (2.1, 3.9) 47 3.2 (3.1, 3.3) 3.5 (3.4, 3.5) 
Melanoma of the Skin 2.8 (2.0, 3.8) 44 3.0 (3.0, 3.1) 2.7 (2.6, 2.7) 
Oral Cavity & Pharynx 2.4 (1.7, 3.3) 40 2.4 (2.4, 2.5) 2.5 (2.5, 2.6) 
Larynx 1.6 (1.1, 2.4) 26 1.1 (1.0, 1.1) 1.1 (1.1, 1.2) 
Hodgkin Lymphoma 0.4 (0.1, 0.9) 6 0.4 (0.4, 0.5) 0.4 (0.4, 0.4) 
Thyroid 0.4 (0.2, 0.9) 7 0.5 (0.5, 0.5) 0.5 (0.5, 0.5) 
Testis See page 29 for gender specific rate 
Ovary See page 30  for gender specific rate 
Corpus Uteri See page 30  for gender specific rate 
Cervix Uteri See page 30 for gender specific rate 
 
Notes: 
   Maine rate is significantly higher than US White rate 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
         Excl. = Excluding; Nerv. = Nervous; Intrahep.= Intrahepatic 
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal pelvis, 
urinary bladder, and cervical cancers, and acute myeloid leukemia 
 
Data Sources: 
 Maine and U.S. Mortality: National Center for Health Statistics, All Causes of Death, Public-Use With State, Total U.S. (1969-
2007) 
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Age-adjusted Cancer Mortality Rates by Site  
Maine, 2007 
     
 Male  
 AA Rate (95% CI) Count US Whites US All Races 
All Malignant Cancers 235.8 (224.2, 247.7) 1616 215.2 (214.4, 216.1) 217.8 (217.0, 218.6) 
Lung and Bronchus 70.4 (64.2, 77.0) 492 64.8 (64.4, 65.3) 65.2 (64.8, 65.7) 
Tobacco-related, Excl. Lung 57.5 (51.9, 63.5) 401 47.7 (47.3, 48.1) 48.1 (47.7, 48.4) 
Prostate 22.5 (18.9, 26.6) 138 21.6 (21.3, 21.9) 23.5 (23.2, 23.8) 
Colon and Rectum 21.8 (18.4, 25.7) 151 19.5 (19.2, 19.7) 20.0 (19.8, 20.3) 
Breast ~ ~ 0.3 (0.2, 0.3) 0.3 (0.2, 0.3) 
Pancreas 12.7 (10.1, 15.6) 89 12.4 (12.2, 12.6) 12.5 (12.3, 12.7) 
Esophagus 11.3 (8.9, 14.1) 80 7.8 (7.7, 8.0) 7.7 (7.5, 7.8) 
Urinary Bladder 11.0 (8.6, 13.9) 74 8.0 (7.8, 8.1) 7.6 (7.4, 7.7) 
Leukemia 10.2 (7.9, 12.9) 69 8.4 (8.2, 8.6) 8.1 (7.9, 8.2) 
Non-Hodgkin Lymphoma 9.5 (7.3, 12.2) 64 8.6 (8.4, 8.8) 8.3 (8.1, 8.4) 
Kidney & Renal Pelvis 6.3 (4.6, 8.5) 45 5.9 (5.7, 6.0) 5.8 (5.7, 5.9) 
Liver & Intrahep. Bile Duct 6.0 (4.3, 8.1) 45 7.2 (7.1, 7.4) 7.9 (7.8, 8.1) 
Stomach 5.3 (3.7, 7.3) 36 4.4 (4.2, 4.5) 5.0 (4.9, 5.1) 
Melanoma of the Skin 4.1 (2.8, 6.0) 29 4.5 (4.4, 4.6) 4.0 (3.9, 4.1) 
Brain & Other Nerv. System 3.9 (2.6, 5.7) 28 5.5 (5.4, 5.6) 5.1 (5.0, 5.2) 
Oral Cavity & Pharynx 3.7 (2.4, 5.4) 27 3.7 (3.6, 3.8) 3.9 (3.7, 4.0) 
Myeloma 3.3 (2.0, 5.0) 21 4.2 (4.0, 4.3) 4.4 (4.3, 4.5) 
Larynx 2.3 (1.3, 3.9) 16 1.9 (1.8, 2.0) 2.1 (2.0, 2.1) 
Hodgkin Lymphoma ~ ~ 0.5 (0.5, 0.6) 0.5 (0.5, 0.5) 
Testis ~ ~ 0.2 (0.2, 0.3) 0.2 (0.2, 0.2) 
Thyroid ~ ~ 0.5 (0.5, 0.6) 0.5 (0.5, 0.6) 
 
 
Notes: 
   Maine rate is significantly higher than US White rate 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
         Excl. = Excluding; Nerv. = Nervous; Intrahep.= Intrahepatic 
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal pelvis, 
urinary bladder, and cervical cancers, and acute myeloid leukemia 
 ~Rate suppressed because number of deaths fewer than 6 
 
Data Sources: 
 Maine and U.S. Mortality: National Center for Health Statistics, All Causes of Death, Public-Use With State, Total U.S. (1969-
2007) 
 
 
 
 
 
  
30 
                                                                                                                                   Annual Cancer Report 2011  
Age-adjusted Cancer Mortality Rates by Site  
Maine, 2007 
     
 Female 
 AA Rate (95% CI) Count US Whites US All Races 
All Malignant Cancers 163.6 (155.3, 172.3) 1496 150.6 (150.0, 151.2) 150.9 (150.3, 151.4) 
Lung and Bronchus 46.5 (42.1, 51.2) 421 41.1 (40.8, 41.5) 40.0 (39.7, 40.3) 
Tobacco-related, Excl. Lung 27.2 (23.9, 30.9) 252 23.9 (23.7, 24.2) 24.7 (24.5, 25.0) 
Breast 20.3 (17.4, 23.5) 184 22.2 (22.0, 22.5) 22.8 (22.6, 23.1) 
Colon and Rectum 17.0 (14.4, 19.9) 162 13.7 (13.5, 13.9) 14.1 (14.0, 14.3) 
Prostate  See page 29 for gender specific rate 
Pancreas 8.7 (6.9, 10.9) 82 9.1 (9.0, 9.3) 9.4 (9.2, 9.5) 
Ovary 7.5 (5.8, 9.6) 67 8.6 (8.4, 8.7) 8.2 (8.1, 8.4) 
Brain & Other Nerv. System 4.8 (3.4, 6.6) 41 3.8 (3.7, 3.9) 3.5 (3.4, 3.6) 
Corpus Uteri 4.8 (3.4, 6.5) 43 3.9 (3.8, 4.0) 4.2 (4.1, 4.3) 
Non-Hodgkin Lymphoma 4.4 (3.2, 6.1) 41 5.4 (5.3, 5.5) 5.2 (5.1, 5.3) 
Leukemia 4.1 (2.8, 5.8) 35 4.6 (4.5, 4.7) 4.5 (4.4, 4.6) 
Kidney & Renal Pelvis 3.8 (2.6, 5.3) 34 2.7 (2.6, 2.8) 2.6 (2.6, 2.7) 
Liver & Intrahep. Bile Duct 3.6 (2.5, 5.2) 33 3.1 (3.0, 3.2) 3.2 (3.2, 3.3) 
Urinary Bladder 3.6 (2.5, 5.1) 35 2.2 (2.1, 2.3) 2.2 (2.1, 2.3) 
Myeloma 2.8 (1.8, 4.1) 26 2.5 (2.4, 2.6) 2.8 (2.7, 2.9) 
Stomach 2.3 (1.4, 3.5) 23 2.2 (2.1, 2.3) 2.6 (2.5, 2.6) 
Cervix Uteri 2.2 (1.3, 3.5) 19 2.2 (2.1, 2.3) 2.4 (2.3, 2.5) 
Melanoma of the Skin 1.8 (1.0, 3.1) 15 1.9 (1.8, 2.0) 1.7 (1.6, 1.7) 
Esophagus 1.7 (1.0, 2.9) 16 1.5 (1.5, 1.6) 1.6 (1.5, 1.6) 
Oral Cavity & Pharynx 1.3 (0.7, 2.3) 13 1.4 (1.3, 1.5) 1.4 (1.4, 1.5) 
Larynx 1.2 (0.5, 2.2) 10 0.4 (0.4, 0.4) 0.4 (0.4, 0.5) 
Thyroid ~ ~ 0.5 (0.4, 0.5) 0.5 (0.4, 0.5) 
Hodgkin Lymphoma ~ ~ 0.3 (0.3, 0.4) 0.3 (0.3, 0.4) 
 
Notes: 
   Maine rate is significantly higher than US White rate 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results;  
         Excl. = Excluding; Nerv. = Nervous; Intrahep.= Intrahepatic 
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal pelvis, 
urinary bladder, and cervical cancers, and acute myeloid leukemia 
 ~Rate suppressed because number of deaths fewer than 6 
Data Sources: 
 Maine and U.S. Mortality: National Center for Health Statistics, All Causes of Death, Public-Use With State, Total U.S. (1969-
2007) 
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Mortality: County and State Comparisons 
 
All Cancers: Mortality by County of Residence 
Maine, 2003-2007 
    
 Total Male  Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 198.5 (187.5, 210.0) 307 235.0 (216.5, 254.7) 152 175.3 (161.5, 190.1) 156 
Aroostook 197.1 (184.9, 210.0) 246 247.3 (226.5, 269.7) 133 160.7 (146.0, 176.6) 113 
Cumberland 196.7 (189.7, 203.9) 766 242.3 (230.1, 254.9) 382 169.8 (161.3, 178.8) 384 
Franklin 210.6 (189.3, 233.8) 91 234.7 (200.4, 273.2) 44 196.7 (169.1, 227.9) 47 
Hancock 203.6 (188.7, 219.4) 176 236.8 (212.4, 263.4) 88 182.3 (163.5, 202.9) 88 
Kennebec 200.6 (190.2, 211.4) 357 244.5 (227.0, 263.0) 186 170.4 (157.7, 184.0) 171 
Knox 183.7 (168.0, 200.5) 130 246.7 (219.1, 277.0) 74 139.7 (121.6, 160.2) 56 
Lincoln 192.0 (175.3, 210.1) 124 224.4 (197.2, 254.7) 63 170.2 (149.2, 193.9) 61 
Oxford 216.7 (201.6, 232.7) 193 278.5 (252.6, 306.4) 108 172.9 (154.8, 192.8) 85 
Penobscot 207.0 (197.1, 217.2) 417 254.8 (237.7, 272.9) 217 174.2 (162.3, 186.8) 200 
Piscataquis 236.0 (209.1, 265.7) 72 270.5 (227.4, 320.0) 36 214.0 (179.5, 254.1) 36 
Sagadahoc 194.6 (175.7, 215.1) 99 244.5 (211.6, 281.1) 52 162.3 (139.4, 187.9) 47 
Somerset 205.7 (189.9, 222.5) 158 264.2 (236.5, 294.3) 86 165.8 (147.1, 186.5) 72 
Waldo 189.2 (171.3, 208.5) 105 222.3 (193.0, 254.8) 55 165.7 (143.4, 190.6) 50 
Washington 222.9 (203.9, 243.4) 129 296.3 (263.4, 332.5) 75 170.0 (147.7, 195.2) 54 
York 191.6 (183.6, 199.8) 550 230.8 (217.4, 244.9) 284 164.8 (155.0, 175.1) 266 
Maine 199.7 (196.6, 202.9) 3916 245.0 (239.6, 250.5) 2032 169.5 (165.6, 173.4) 1884 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval 
 
Data Source: 
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007). 
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Lung Cancer: Mortality by County of Residence 
 Maine, 2003-2007 
 Total Male  Female 
 AA Rate (95% 
CI) 
Count/Yr AA Rate (95% 
CI) 
Count/Yr AA Rate (95% 
CI) 
Count/Yr 
Androscoggin 66.0 (59.7, 72.9) 100 79.2 (68.7, 90.9) 52 56.7 (48.9, 65.5) 48 
Aroostook 62.5 (55.7, 70.0) 78 88.0 (75.9, 101.7) 48 43.4 (35.8, 52.2) 30 
Cumberland 57.6 (53.8, 61.5) 221 73.7 (67.1, 80.8) 118 46.5 (42.1, 51.3) 103 
Franklin 52.2 (41.9, 64.3) 23 60.7 (44.4, 81.2) 12 45.1 (32.5, 61.2) 11 
Hancock 54.4 (46.9, 62.9) 47 64.4 (52.3, 78.7) 25 47.0 (37.7, 58.3) 22 
Kennebec 62.0 (56.3, 68.1) 110 75.7 (66.2, 86.3) 58 52.9 (45.9, 60.8) 52 
Knox 58.6 (49.9, 68.6) 42 84.6 (68.9, 103.1) 26 40.8 (31.1, 52.9) 16 
Lincoln 52.7 (44.0, 62.7) 33 62.6 (48.6, 79.8) 17 46.0 (35.4, 59.4) 16 
Oxford 67.8 (59.5, 77.0) 61 92.2 (77.7, 108.8) 37 50.1 (40.6, 61.5) 24 
Penobscot 62.1 (56.7, 67.7) 127 82.1 (72.7, 92.4) 73 47.2 (41.1, 54.1) 54 
Piscataquis 70.3 (56.3, 87.3) 22 90.1 (66.8, 119.9) 13 54.6 (38.1, 77.0) 9 
Sagadahoc 59.7 (49.4, 71.5) 30 69.5 (52.7, 89.9) 15 52.2 (39.7, 67.6) 15 
Somerset 72.6 (63.4, 82.8) 57 95.2 (79.1, 113.6) 32 56.2 (45.6, 68.8) 25 
Waldo 57.3 (47.7, 68.3) 32 63.6 (48.8, 81.7) 16 51.6 (39.6, 66.3) 16 
Washington 68.5 (58.3, 80.3) 40 89.8 (72.4, 110.5) 23 51.4 (39.6, 66.1) 17 
York 56.8 (52.5, 61.4) 163 70.2 (62.9, 78.1) 87 47.9 (42.6, 53.7) 76 
Maine 60.4 (58.7, 62.2) 1184 76.9 (73.9, 79.9) 651 48.7 (46.6, 50.8) 533 
 
 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Excl. = Excluding 
 
Data Source:  
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
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Tobacco-related Cancers, Excl. Lung: Mortality by County of Residence 
Maine, 2003-2007 
 Total Male  Female 
 
AA Rate (95% 
CI) 
Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% 
CI) 
Count/Yr 
Androscoggin 40.2 (35.3, 45.6) 63 57.9 (48.9, 68.1) 38 26.8 (21.7, 32.9) 25 
Aroostook 35.8 (30.7, 41.6) 45 47.1 (38.3, 57.5) 26 27.6 (21.7, 34.8) 19 
Cumberland 39.5 (36.4, 42.8) 155 55.3 (49.7, 61.5) 91 28.3 (24.9, 32.1) 64 
Franklin 51.8 (41.5, 64.0) 22 64.1 (46.7, 85.8) 12 44.8 (32.1, 61.1) 11 
Hancock 40.3 (33.8, 47.8) 35 56.5 (44.9, 70.3) 21 27.8 (20.9, 36.7) 14 
Kennebec 38.9 (34.4, 43.8) 69 52.1 (44.3, 60.8) 41 27.3 (22.5, 33.0) 28 
Knox 31.9 (25.5, 39.5) 22 52.2 (40.1, 67.0) 16 16.1 (10.3, 24.6) 6 
Lincoln 31.6 (25.2, 39.5) 21 40.6 (29.8, 54.6) 12 24.5 (17.0, 34.8) 9 
Oxford 45.4 (38.6, 53.1) 40 63.8 (51.8, 77.8) 25 30.8 (23.4, 40.0) 15 
Penobscot 38.2 (34.0, 42.7) 77 54.9 (47.1, 63.6) 47 25.9 (21.5, 31.1) 30 
Piscataquis 35.5 (25.7, 48.5) 11 42.8 (27.0, 65.4) 6 30.0 (18.2, 47.9) 5 
Sagadahoc 41.6 (33.0, 51.7) 21 62.4 (46.7, 81.7) 14 24.3 (15.8, 35.9) 7 
Somerset 35.2 (28.9, 42.6) 27 50.7 (39.2, 64.5) 17 23.1 (16.5, 31.8) 10 
Waldo 43.4 (35.1, 53.1) 25 51.5 (38.1, 68.1) 13 37.3 (27.2, 50.1) 12 
Washington 44.3 (36.1, 54.0) 26 73.0 (57.1, 92.3) 18 22.5 (15.1, 32.9) 8 
York 37.1 (33.7, 40.8) 107 55.7 (49.3, 62.7) 71 22.6 (19.1, 26.7) 37 
Maine 38.9 (37.5, 40.3) 765 54.9 (52.4, 57.5) 466 26.6 (25.1, 28.2) 299 
 
 
 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary ladder, and cervical cancers, and acute myeloid leukemia 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Excl. = Excluding 
 
Data Source:  
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
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Notes: 
   County rate is significantly higher than Maine rate 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval 
 
Data Source: 
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prostate Cancer: Mortality 
 by County of Residence  
Maine, 2003-2007 
  
 Male  
 AA Rate (95% CI) Count/Yr 
Androscoggin 19.8 (14.5, 26.4) 12 
Aroostook 11.4 (7.2, 17.3) 6 
Cumberland 28.2 (24.0, 33.0) 40 
Franklin 19.1 (10.0, 33.0) 3 
Hancock 27.3 (19.3, 37.6) 10 
Kennebec 28.5 (22.5, 35.7) 19 
Knox 25.0 (16.6, 36.3) 7 
Lincoln 36.2 (25.7, 49.9) 10 
Oxford 28.1 (19.9, 38.5) 10 
Penobscot 21.3 (16.3, 27.4) 16 
Piscataquis 47.5 (30.0, 72.2) 6 
Sagadahoc 31.9 (20.1, 47.7) 6 
Somerset 23.8 (15.7, 34.6) 7 
Waldo 27.4 (17.3, 41.1) 6 
Washington 22.6 (14.1, 34.6) 6 
York 25.8 (21.2, 31.1) 28 
Maine 25.4 (23.6, 27.3) 190 
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Female Breast Cancer: Mortality 
 by County of Residence  
Maine, 2003-2007 
  
 Female 
 AA Rate (95% CI) Count/Yr 
Androscoggin 27.3 (22.0, 33.6) 24 
Aroostook 18.9 (14.0, 25.1) 13 
Cumberland 22.9 (19.8, 26.3) 52 
Franklin 24.9 (15.8, 37.8) 6 
Hancock 25.2 (18.4, 33.9) 12 
Kennebec 19.6 (15.4, 24.7) 19 
Knox 23.8 (16.5, 33.7) 9 
Lincoln 21.2 (14.1, 31.3) 7 
Oxford 24.1 (17.7, 32.4) 12 
Penobscot 26.4 (21.8, 31.7) 30 
Piscataquis 22.5 (12.2, 39.2) 4 
Sagadahoc 21.9 (14.1, 32.8) 6 
Somerset 18.7 (12.9, 26.6) 8 
Waldo 11.9 (6.7, 20.1) 4 
Washington 24.2 (15.9, 35.6) 7 
York 22.1 (18.5, 26.1) 35 
Maine 22.6 (21.2, 24.1) 248 
 
Notes: 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Excl. = Excluding 
 
Data Source: 
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
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Colorectal Cancer: Mortality by County of Residence 
Maine, 2003-2007 
    
 Total Male  Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 17.0 (13.9, 20.5) 27 21.1 (15.8, 27.6) 14 13.8 (10.3, 18.4) 13 
Aroostook 20.6 (16.8, 25.1) 26 25.6 (19.1, 33.6) 14 16.7 (12.3, 22.5) 12 
Cumberland 19.7 (17.5, 22.0) 77 23.1 (19.4, 27.3) 36 17.4 (14.8, 20.4) 41 
Franklin 24.9 (17.8, 34.0) 10 29.6 (18.1, 45.7) 5 22.3 (13.4, 35.1) 5 
Hancock 15.9 (12.0, 20.8) 15 15.8 (10.0, 24.0) 6 16.7 (11.5, 23.8) 9 
Kennebec 16.7 (13.8, 20.0) 30 18.7 (14.0, 24.3) 14 15.3 (11.7, 19.6) 16 
Knox 11.8 (8.2, 16.8) 8 14.9 (8.7, 24.1) 4 9.9 (5.7, 16.7) 4 
Lincoln 16.7 (12.1, 22.7) 12 16.8 (10.0, 26.8) 5 15.9 (10.3, 24.4) 7 
Oxford 19.3 (15.0, 24.5) 17 26.3 (18.8, 36.0) 10 14.0 (9.3, 20.6) 7 
Penobscot 18.5 (15.7, 21.8) 38 19.4 (14.9, 24.8) 17 17.6 (14.0, 22.0) 21 
Piscataquis 25.8 (17.4, 37.4) 8 31 (17.0, 52.3) 4 22.4 (12.6, 38.4) 4 
Sagadahoc 16.2 (11.1, 22.8) 8 20.2 (11.6, 32.6) 4 13.7 (7.8, 22.7) 4 
Somerset 19.4 (14.7, 25.1) 15 14.9 (8.8, 23.4) 5 22.1 (15.7, 30.4) 10 
Waldo 14.9 (10.2, 21.1) 9 18.8 (11.1, 29.9) 5 11.4 (6.2, 19.5) 4 
Washington 20.7 (15.2, 27.7) 12 25.0 (16.1, 37.4) 6 17.3 (10.8, 26.8) 6 
York 17.3 (15.0, 19.9) 51 18.6 (15.0, 22.9) 24 15.9 (13.0, 19.3) 27 
Maine 18.2 (17.3, 19.2) 360 20.8 (19.3, 22.5) 171 16.3 (15.1, 17.5) 189 
 
Notes: 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval 
 
Data Source: 
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
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Mortality: District and State Comparisons 
 
All Cancers: Mortality by Public Health District of Residence 
Maine, 2003-2007 
     
 
Total Male  Female 
AA Rate (95% CI) Count/Yr  AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 197.1 (184.9, 210.0) 246 247.3 (226.5, 269.7) 133 160.7 (146.0, 176.6) 113 
Central 202 (193.3, 211.0) 515 250.2 (235.3, 265.8) 272 169.0 (158.4, 180.1) 243 
Cumberland 196.7 (189.7, 203.9) 766 242.3 (230.1, 254.9) 382 169.8 (161.3, 178.8) 384 
Downeast 210.9 (199.2, 223.3) 305 260.3 (240.5, 281.4) 163 176.9 (162.5, 192.5) 142 
Midcoast 189.7 (181.0, 198.7) 456 234.6 (219.9, 250.1) 242 158.8 (148.2, 170.1) 214 
Penquis 210.9 (201.6, 220.5) 488 257.3 (241.3, 274.1) 253 179.2 (167.8, 191.1) 235 
Western 205.7 (197.4, 214.2) 591 248.7 (234.8, 263.3) 304 177.3 (167.0, 188.1) 287 
York 191.6 (183.6, 199.8) 550 230.8 (217.4, 244.9) 284 164.8 (155.0, 175.1) 266 
Maine 199.7 (196.6, 202.9) 3916 245.0 (239.6, 250.5) 2032 169.5 (165.6, 173.4) 1884 
 
 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval 
 
Data Source: 
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
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Lung Cancer: Mortality by Public Health District of Residence 
Maine, 2003-2007 
    
 Total Male  Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 62.5 (55.7, 70.0) 78 88.0 (75.9, 101.7) 48 43.4 (35.8, 52.2) 30 
Central 65.1 (60.2, 70.3) 166 81.5 (73.2, 90.5) 90 53.8 (47.9, 60.3) 76 
Cumberland 57.6 (53.8, 61.5) 221 73.7 (67.1, 80.8) 118 46.5 (42.1, 51.3) 103 
Downeast 60.0 (53.9, 66.8) 87 74.5 (64.3, 86.0) 48 48.8 (41.3, 57.3) 39 
Midcoast 57.0 (52.3, 62.0) 137 70.9 (63.0, 79.6) 74 46.9 (41.2, 53.2) 63 
Penquis 63.2 (58.2, 68.5) 148 83.3 (74.5, 92.9) 85 48.2 (42.4, 54.6) 63 
Western 64.2 (59.6, 69.1) 184 80.3 (72.6, 88.7) 101 52.7 (47.1, 58.8) 83 
York 56.8 (52.5, 61.4) 163 70.2 (62.9, 78.1) 87 47.9 (42.6, 53.7) 76 
Maine 60.4 (58.7, 62.2) 1184 76.9 (73.9, 79.9) 651 48.7 (46.6, 50.8) 533 
 
 
Tobacco-related Cancers, Excl. Lung: Mortality 
 by Public Health District of Residence 
 Maine, 2003-2007 
    
 Total Male  Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 35.8 (30.7, 41.6) 45 47.1 (38.3, 57.5) 26 27.6 (21.7, 34.8) 19 
Central 37.7 (34.0, 41.7) 97 51.5 (45.0, 58.7) 58 26.0 (22.0, 30.6) 38 
Cumberland 39.5 (36.4, 42.8) 155 55.3 (49.7, 61.5) 91 28.3 (24.9, 32.1) 64 
Downeast 41.9 (36.7, 47.6) 61 63.0 (53.4, 73.9) 39 25.7 (20.5, 32.1) 21 
Midcoast 36.6 (32.8, 40.7) 88 50.9 (44.3, 58.2) 55 25.1 (21.0, 29.9) 34 
Penquis 37.8 (34.0, 42.0) 88 53.2 (46.1, 61.1) 53 26.4 (22.2, 31.2) 35 
Western 43.6 (39.8, 47.6) 125 60.7 (53.9, 68.1) 75 30.8 (26.6, 35.5) 51 
York 37.1 (33.7, 40.8) 107 55.7 (49.3, 62.7) 71 22.6 (19.1, 26.7) 37 
Maine 38.9 (37.5, 40.3) 765 54.9 (52.4, 57.5) 466 26.6 (25.1, 28.2) 299 
 
Notes: 
   County rate is significantly higher than Maine rate 
 Tobacco-related cancers, excl. lung = laryngeal, oropharyngeal, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, and cervical cancers, and acute myeloid leukemia 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval 
 
Data Source: 
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
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Prostate Cancer: Mortality  
by Public Health District of Residence 
Maine, 2003-2007 
  
 Male  
 AA Rate (95% CI) Count/Yr 
Aroostook 11.4 (7.2, 17.3) 6 
Central 27.3 (22.2, 33.1) 26 
Cumberland 28.2 (24.0, 33.0) 40 
Downeast 25.3 (19.3, 32.7) 15 
Midcoast 30.1 (24.8, 36.2) 29 
Penquis 25.2 (20.1, 31.3) 22 
Western 22.4 (18.1, 27.3) 25 
York 25.8 (21.2, 31.1) 28 
Maine 25.4 (23.6, 27.3) 190 
 
 
 
Female Breast Cancer: Mortality 
 by Public Health District of Residence 
Maine, 2003-2007 
  
 Female 
 AA Rate (95% CI) Count/Yr 
Aroostook 18.9 (14.0, 25.1) 13 
Central 19.3 (15.8, 23.4) 27 
Cumberland 22.9 (19.8, 26.3) 52 
Downeast 24.8 (19.4, 31.3) 19 
Midcoast 19.8 (16.1, 24.1) 26 
Penquis 25.9 (21.7, 30.8) 34 
Western 26.0 (22.2, 30.4) 42 
York 22.1 (18.5, 26.1) 35 
Maine 22.6 (21.2, 24.1) 248 
 
Notes: 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval 
 
Data Source: 
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
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Colorectal Cancer: Mortality by Public Health District of Residence  
Maine, 2003-2007 
    
 Total Male  Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 20.6 (16.8, 25.1) 26 25.6 (19.1, 33.6) 14 16.7 (12.3, 22.5) 12 
Central 17.5 (15.0, 20.3) 45 17.6 (13.8, 22.1) 19 17.3 (14.1, 21.1) 26 
Cumberland 19.7 (17.5, 22.0) 77 23.1 (19.4, 27.3) 36 17.4 (14.8, 20.4) 41 
Downeast 17.7 (14.5, 21.6) 26 19.3 (14.2, 25.8) 12 16.9 (12.7, 22.2) 14 
Midcoast 14.9 (12.5, 17.5) 36 17.6 (13.7, 22.2) 18 12.7 (9.9, 16.1) 18 
Penquis 19.5 (16.7, 22.6) 45 21.1 (16.6, 26.3) 21 18.3 (14.8, 22.4) 25 
Western 18.8 (16.4, 21.5) 54 23.9 (19.7, 28.8) 29 15.1 (12.2, 18.5) 25 
York 17.3 (15.0, 19.9) 50 18.6 (15.0, 22.9) 24 15.9 (13.0, 19.3) 27 
Maine 18.2 (17.3,19.2) 360 20.8 (19.3, 22.5) 171 16.3 (15.1, 17.5) 189 
 
Notes: 
 Mortality case definitions are based on ICD-10 codes (see page 7) 
 Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population. 
 Abbreviations: AA = Age-adjusted; CI = Confidence Interval 
 
Data Source: 
 National Center for Health Statistics, All Causes of Death, Public-Use With County, Total U.S. (1969-2007) 
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